Search

everythinglearnresearchcommunity

for

Search:↓

Temporal triangular alopecia is a harmless, non-progressive hair loss condition.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

A woman with a rare hair loss condition developed skin cancer in the bald area.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Temporal triangular alopecia causes permanent hair loss and can be managed with treatments like minoxidil or hair transplantation.

Histopathological confirmation is crucial to accurately diagnose alopecia triangular temporal and avoid unnecessary treatments.

ATP-sensitive potassium channels are important for hair growth.

The condition is harmless, doesn't worsen, and needs no invasive treatment.

The trial aims to understand how obesity and lifestyle affect circadian rhythms in people with schizophrenia and bipolar disorder.

The combination treatment showed a higher response rate but no significant survival benefits.

5% topical minoxidil effectively treated a boy's congenital triangular alopecia without side effects.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).

Using both minoxidil and finasteride together on the scalp works better for male hair loss than using either one alone.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

Hispanic and Black patients are underrepresented in alopecia areata clinical trials.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

A five-year-old girl has a harmless, unchanging bald patch on her scalp.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

The hair growth serum was tested for safety and if it works in people with hair loss and for healthier hair.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

The report concludes that atypical Brauer nevus is more common in males, present at birth, and often misdiagnosed due to its unusual scalp locations.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

Trichoscopic examination is crucial for diagnosing congenital triangular alopecia.

A 5-year-old boy was diagnosed with congenital triangular alopecia, a type of hair loss without skin changes, usually starting between ages 2-5, with no specific treatment.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Alopecia triangular temporal is a rare condition with unclear causes and treatment, but trichoscopy helps in diagnosis.

The document suggests a clinical trial to accurately determine if PRP is an effective treatment for a common type of hair loss in men.